Analystreport

RXi Pharmaceuticals Corp (NASDAQ: RXII) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating.

RXI PHARMACEUTICALS CORP  (RXII) 
Last rxi pharmaceuticals corp earnings: 11/14 07:10 am Check Earnings Report
US:NASDAQ Investor Relations: investors.rxipharma.com